Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2001 Apr;51(465):276-9.

Patients' responses to risk information about the benefits of treating hypertension

Affiliations
Comparative Study

Patients' responses to risk information about the benefits of treating hypertension

D Misselbrook et al. Br J Gen Pract. 2001 Apr.

Abstract

Background: The medical profession is often presented with information on the value of treatment in terms of likely risk reduction. If this same information was presented to patients--so enabling them to give proper informed consent--would this affect their decision to be treated?

Aim: To examine patients' choice about treatment in response to different forms of risk presentation.

Design of study: Postal questionnaire study.

Setting: The questionnaire was sent to 102 hypertensive patients and 207 matched non-hypertensive patients aged between 35 and 65 years in a UK general practice.

Methods: Patients were asked the likelihood, on a four-point scale, of their accepting treatment for a chronic condition (mild hypertension) on the basis of relative risk reduction, absolute risk reduction, number needed to treat, and personal probability of benefit.

Results: An 89% response rate was obtained. Of these, 92% would accept treatment using a relative risk reduction model, 75% would accept treatment using an absolute risk reduction model, 68% would accept treatment using a number needed to treat model, and 44% would accept treatment with a personal probability of benefit model.

Conclusion: Many patients may prefer not to take treatment for mild hypertension if the risks were fully explained. However, given that the form of the explanation has a strong influence on the patient's decision, it is not clear how decision-making can be fully shared nor what should constitute informed consent to treatment in this situation.

PubMed Disclaimer

Comment in

  • Risks--listen and don't mislead.
    Edwards A, Elwyn GJ. Edwards A, et al. Br J Gen Pract. 2001 Apr;51(465):259-60. Br J Gen Pract. 2001. PMID: 11458474 Free PMC article. No abstract available.

References

    1. N Engl J Med. 1978 Oct 5;299(14):741-4 - PubMed
    1. N Engl J Med. 1982 May 27;306(21):1259-62 - PubMed
    1. J R Coll Gen Pract. 1982 Feb;32(235):103-5 - PubMed
    1. J Epidemiol Community Health. 1985 Sep;39(3):197-209 - PubMed
    1. J R Coll Gen Pract. 1989 May;39(322):193-5 - PubMed

Publication types